Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia Kaiafa

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Blood Cancer Journal|March 11, 2018
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study GroupEirini Katodritou, Evangelos Terpos, Sossana Delimpasi, et al.
Frontiers in Medicine|October 30, 2023
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter dataEleni Gavriilaki, Emmanuel Nikolousis, Eudoxia-Evaggelia Koravou, et al.
Viruses|April 23, 2022
Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT StudyKarolina Akinosoglou, Christos Savopoulos, Abraham Pouliakis, et al.
Cancers|May 14, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)Argiris Symeonidis, Panagiotis Diamantopoulos, Athanasios Galanopoulos, et al.
American Journal of Hematology|August 13, 2024
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodesJeremy W Jacobs, Caroline G Stanek, Garrett S Booth, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Blood Cancer Journal|March 11, 2018
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study GroupEirini Katodritou, Evangelos Terpos, Sossana Delimpasi, et al.
Frontiers in Medicine|October 30, 2023
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter dataEleni Gavriilaki, Emmanuel Nikolousis, Eudoxia-Evaggelia Koravou, et al.
Viruses|April 23, 2022
Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT StudyKarolina Akinosoglou, Christos Savopoulos, Abraham Pouliakis, et al.
Cancers|May 14, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)Argiris Symeonidis, Panagiotis Diamantopoulos, Athanasios Galanopoulos, et al.
American Journal of Hematology|August 13, 2024
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodesJeremy W Jacobs, Caroline G Stanek, Garrett S Booth, et al.
Pageof 9